| Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications P Nahon, V Bourcier, R Layese, E Audureau, C Cagnot, P Marcellin, ... Gastroenterology 152 (1), 142-156. e2, 2017 | 577 | 2017 |
| Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC)–NCT01514890 C Hézode, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, ... Journal of hepatology 59 (3), 434-441, 2013 | 557 | 2013 |
| Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study F Carrat, H Fontaine, C Dorival, M Simony, C Hezode, V De Ledinghen, ... The Lancet 393 (10179), 1453-1464, 2019 | 545 | 2019 |
| Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ... The Lancet Infectious Diseases 17 (5), 510-519, 2017 | 490 | 2017 |
| Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease C Bureau, S Metivier, JM Peron, J Selves, MA Robic, PA Gourraud, ... Alimentary pharmacology & therapeutics 27 (12), 1261-1268, 2008 | 456 | 2008 |
| Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 … E Lawitz, E Gane, B Pearlman, E Tam, W Ghesquiere, D Guyader, L Alric, ... The Lancet 385 (9973), 1075-1086, 2015 | 375 | 2015 |
| Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a … M Bourlière, JP Bronowicki, V De Ledinghen, C Hézode, F Zoulim, ... The Lancet Infectious Diseases 15 (4), 397-404, 2015 | 372 | 2015 |
| Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection N Kamar, L Rostaing, F Abravanel, C Garrouste, S Lhomme, L Esposito, ... Gastroenterology 139 (5), 1612-1618, 2010 | 352 | 2010 |
| Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis C Hézode, H Fontaine, C Dorival, F Zoulim, D Larrey, V Canva, ... Gastroenterology 147 (1), 132-142. e4, 2014 | 333 | 2014 |
| Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy JM Peron, C Bureau, H Poirson, JM Mansuy, L Alric, J Selves, E Dupuis, ... Journal of viral hepatitis 14 (5), 298-303, 2007 | 306 | 2007 |
| Hepatitis E in the south west of France in individuals who have never visited an endemic area JM Mansuy, JM Peron, F Abravanel, H Poirson, M Dubois, M Miedouge, ... Journal of medical virology 74 (3), 419-424, 2004 | 305 | 2004 |
| Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection L Alric, M Fort, J Izopet, JP Vinel, JP Charlet, J Selves, J Puel, JP Pascal, ... Gastroenterology 113 (5), 1675-1681, 1997 | 295 | 1997 |
| “A la carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding C Bureau, JM Péron, L Alric, J Morales, J Sanchez, K Barange, JL Payen, ... Hepatology 36 (6), 1361-1366, 2002 | 290 | 2002 |
| Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis JP Motta, LG Bermúdez-Humarán, C Deraison, L Martin, C Rolland, ... Science translational medicine 4 (158), 158ra144-158ra144, 2012 | 258 | 2012 |
| Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ... Annals of internal medicine 158 (4), 235-245, 2013 | 247 | 2013 |
| Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation N Kamar, O Marion, L Rostaing, O Cointault, D Ribes, L Lavayssière, ... American Journal of Transplantation 16 (5), 1474-1479, 2016 | 242 | 2016 |
| Hepatitis E virus and the kidney in solid-organ transplant patients N Kamar, H Weclawiak, C Guilbeau-Frugier, F Legrand-Abravanel, ... Transplantation 93 (6), 617-623, 2012 | 234 | 2012 |
| Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs P Nahon, R Layese, V Bourcier, C Cagnot, P Marcellin, D Guyader, S Pol, ... Gastroenterology 155 (5), 1436-1450. e6, 2018 | 228 | 2018 |
| Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN L Alric, E Plaisier, S Thébault, JM Péron, L Rostaing, J Pourrat, P Ronco, ... American Journal of Kidney Diseases 43 (4), 617-623, 2004 | 224 | 2004 |
| High prevalence of anti‐hepatitis E virus antibodies in blood donors from South West France JM Mansuy, F Legrand‐Abravanel, JP Calot, JM Peron, L Alric, S Agudo, ... Journal of medical virology 80 (2), 289-293, 2008 | 214 | 2008 |
